{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T17:03:29Z","timestamp":1788023009646,"version":"build-2784847793"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jconrel.2024.03.004","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T16:20:45Z","timestamp":1709914845000},"page":"466-480","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Placenta-anchored tadalafil liposomes rescues intrauterine growth restriction through continuous placental blood perfusion improvement"],"prefix":"10.1016","volume":"368","author":[{"given":"Miao","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunchun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongli","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caihong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2024.03.004_bb0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ijgo.13522","article-title":"FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction","volume":"152","author":"Melamed","year":"2021","journal-title":"Int. J. Gynecol. Obstet."},{"key":"10.1016\/j.jconrel.2024.03.004_bb0010","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/aogs.13699","article-title":"Pathologic placental lesions in early and late fetal growth restriction","volume":"98","author":"Spinillo","year":"2019","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.jconrel.2024.03.004_bb0015","doi-asserted-by":"crossref","first-page":"S745","DOI":"10.1016\/j.ajog.2017.11.577","article-title":"Pathophysiology of placental-derived fetal growth restriction","volume":"218","author":"Burton","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jconrel.2024.03.004_bb0020","article-title":"Pre-eclampsia: pathophysiology and clinical implications","volume":"366","author":"Burton","year":"2019","journal-title":"BMJ (Clin. Res. ed.)"},{"key":"10.1016\/j.jconrel.2024.03.004_bb0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.placenta.2021.01.007","article-title":"Placental blood flow sensing and regulation in fetal growth restriction","volume":"113","author":"Morley","year":"2021","journal-title":"Placenta"},{"key":"10.1016\/j.jconrel.2024.03.004_bb0030","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrd893","article-title":"Phosphodiesterase 5 inhibitors: current status and potential applications","volume":"1","author":"Rotella","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2024.03.004_bb0035","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/14767058.2017.1306509","article-title":"Utero-placental perfusion Doppler indices in growth restricted fetuses: effect of sildenafil citrate","volume":"31","author":"El-Sayed","year":"2018","journal-title":"J. Maternal-Fetal Neonatal Med."},{"key":"10.1016\/j.jconrel.2024.03.004_bb0040","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.placenta.2020.06.015","article-title":"Effect and mechanism of prophylactic use of tadalafil during pregnancy on l-NAME-induced preeclampsia-like rats","volume":"99","author":"Li","year":"2020","journal-title":"Placenta"},{"key":"10.1016\/j.jconrel.2024.03.004_bb0045","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/jog.13218","article-title":"Retrospective study of tadalafil for fetal growth restriction: impact on maternal and perinatal outcomes","volume":"43","author":"Kubo","year":"2017","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.jconrel.2024.03.004_bb0050","doi-asserted-by":"crossref","first-page":"856","DOI":"10.3390\/jcm8060856","article-title":"Safety evaluation of tadalafil treatment for fetuses with early-onset growth restriction (TADAFER): results from the phase II trial","volume":"8","author":"Maki","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jconrel.2024.03.004_bb0055","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.3390\/jcm9051448","article-title":"Developmental evaluation of infants who have received tadalafil in utero for fetal growth restriction","volume":"9","author":"Maki","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jconrel.2024.03.004_bb0060","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1080\/10837450.2019.1631846","article-title":"Intranasal Tadalafil nanoemulsions: formulation, characterization and pharmacodynamic evaluation","volume":"24","author":"Elbardisy","year":"2019","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.jconrel.2024.03.004_bb0065","doi-asserted-by":"crossref","first-page":"567","DOI":"10.5650\/jos.ess13236","article-title":"Solubility and dissolution enhancement of tadalafil using self-nanoemulsifying drug delivery system","volume":"63","author":"El-Badry","year":"2014","journal-title":"J. Oleo Sci."},{"key":"10.1016\/j.jconrel.2024.03.004_bb0070","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1080\/14767058.2019.1624717","article-title":"Phase-1 clinical study of tadalafil administered for selective fetal growth restriction in twin pregnancy","volume":"34","author":"Magawa","year":"2021","journal-title":"J. Maternal-Fetal Neonatal Med.: Off. J. Eur. Assoc. Perinat. Med. Feder. Asia Ocean. Perinat. Soc. Intern. Soc. Perinat. Obst."},{"key":"10.1016\/j.jconrel.2024.03.004_bb0075","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/humupd\/dmaa049","article-title":"Nanoparticles in pregnancy: the next frontier in reproductive therapeutics","volume":"27","author":"Pritchard","year":"2021","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.jconrel.2024.03.004_bb0080","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.placenta.2018.01.006","article-title":"Knowledge needed about the exchange physiology of the placenta","volume":"64","author":"Sibley","year":"2018","journal-title":"Placenta"},{"key":"10.1016\/j.jconrel.2024.03.004_bb0085","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jpedsurg.2013.09.024","article-title":"Antenatal maternally-administered phosphodiesterase type 5 inhibitors normalize eNOS expression in the fetal lamb model of congenital diaphragmatic hernia","volume":"49","author":"Shue","year":"2014","journal-title":"J. Pediatr. Surg."},{"key":"10.1016\/j.jconrel.2024.03.004_bb0090","doi-asserted-by":"crossref","first-page":"2184315","DOI":"10.1080\/10717544.2023.2184315","article-title":"Advance in placenta drug delivery: concern for placenta-originated disease therapy","volume":"30","author":"Tang","year":"2023","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2024.03.004_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122121","article-title":"Size-dependent placental retention effect of liposomes in ICR pregnant mice: potential superiority in placenta-derived disease therapy","volume":"625","author":"Tang","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2024.03.004_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nano.2012.05.013","article-title":"The big picture on nanomedicine: the state of investigational and approved nanomedicine products","volume":"9","author":"Etheridge","year":"2013","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2024.03.004_bb0105","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2147\/IJN.S68861","article-title":"Liposomes as nanomedical devices","volume":"10","author":"Bozzuto","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2024.03.004_bb0110","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.3390\/pharmaceutics13111778","article-title":"Targeted delivery of epidermal growth factor to the human placenta to treat fetal growth restriction","volume":"13","author":"Renshall","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2024.03.004_bb0115","doi-asserted-by":"crossref","first-page":"34710","DOI":"10.1038\/srep34710","article-title":"Uterus-targeted liposomes for preterm labor management: studies in pregnant mice","volume":"6","author":"Refuerzo","year":"2016","journal-title":"Sci. Rep."},{"issue":"283","key":"10.1016\/j.jconrel.2024.03.004_bb0120","first-page":"e281","article-title":"Drug delivery to the human and mouse uterus using immunoliposomes targeted to the oxytocin receptor","volume":"216","author":"Paul","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jconrel.2024.03.004_bb0125","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.placenta.2019.02.002","article-title":"The untapped potential of placenta-enriched molecules for diagnostic and therapeutic development","volume":"84","author":"Whigham","year":"2019","journal-title":"Placenta"},{"key":"10.1016\/j.jconrel.2024.03.004_bb0130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.placenta.2021.03.003","article-title":"A crossroad between placental and tumor biology: what have we learnt?","volume":"116","author":"Lala","year":"2021","journal-title":"Placenta"},{"key":"10.1016\/j.jconrel.2024.03.004_bb0135","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jconrel.2023.06.003","article-title":"Nanomedicines: an approach to treat placental insufficiency and the current challenges","volume":"360","author":"van Kammen","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.03.004_bb0140","doi-asserted-by":"crossref","first-page":"12285","DOI":"10.1039\/C8NR10337B","article-title":"IGF signalling and endocytosis in the human villous placenta in early pregnancy as revealed by comparing quantum dot conjugates with a soluble ligand","volume":"11","author":"Karolczak-Bayatti","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2024.03.004_bb0145","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1600349","article-title":"Tumor-homing peptides as tools for targeted delivery of payloads to the placenta","volume":"2","author":"King","year":"2016","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2024.03.004_bb0150","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.placenta.2004.06.003","article-title":"Endothelin and the regulation of uteroplacental perfusion in nitric oxide synthase inhibition-induced fetal growth restriction","volume":"26","author":"Thaete","year":"2005","journal-title":"Placenta"},{"key":"10.1016\/j.jconrel.2024.03.004_bb0155","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3109\/10641950903322915","article-title":"Pathophysiology of chronic nitric oxide synthase inhibition-induced fetal growth restriction in the rat","volume":"30","author":"Neerhof","year":"2011","journal-title":"Hypertens. Pregn."},{"key":"10.1016\/j.jconrel.2024.03.004_bb0160","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.reprotox.2014.09.010","article-title":"Surface charge and dosage dependent potential developmental toxicity and biodistribution of iron oxide nanoparticles in pregnant CD-1 mice","volume":"50","author":"Di Bona","year":"2014","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.jconrel.2024.03.004_bb0165","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ijpharm.2017.01.031","article-title":"RGD conjugated liposome-hollow silica hybrid nanovehicles for targeted and controlled delivery of arsenic trioxide against hepatic carcinoma","volume":"519","author":"Fei","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2024.03.004_bb0170","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.7150\/thno.19678","article-title":"Selective targeting of a novel vasodilator to the uterine vasculature to treat impaired Uteroplacental perfusion in pregnancy","volume":"7","author":"Cureton","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2024.03.004_bb0175","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1080\/14767058.2018.1438401","article-title":"Cardiac function and tadalafil used for treating fetal growth restriction in pregnant women without cardiovascular disease","volume":"32","author":"Tanaka","year":"2019","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.jconrel.2024.03.004_bb0180","doi-asserted-by":"crossref","first-page":"9131","DOI":"10.1080\/14767058.2021.2017873","article-title":"Assessment of the value of measuring soluble fms-like tyrosine kinase-1 and placental growth factor levels following administration of tadalafil to treat fetal growth restriction","volume":"35","author":"Tanaka","year":"2022","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.jconrel.2024.03.004_bb0185","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/ajh\/hpx130","article-title":"Tadalafil improves L-NG-Nitroarginine methyl Ester-induced preeclampsia with fetal growth restriction-like symptoms in pregnant mice","volume":"31","author":"Yoshikawa","year":"2017","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.jconrel.2024.03.004_bb0190","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.acthis.2018.03.002","article-title":"An immunohistochemical and ultrastructural analysis of the retina in tadalafil (Cialis) treated rats","volume":"120","author":"Sarhan","year":"2018","journal-title":"Acta Histochem."},{"key":"10.1016\/j.jconrel.2024.03.004_bb0195","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1007\/s12035-015-9293-0","article-title":"NF-\u03baB upregulates type 5 phosphodiesterase in N9 microglial cells: inhibition by sildenafil and yonkenafil","volume":"53","author":"Zhao","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jconrel.2024.03.004_bb0200","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1021\/acsbiomaterials.0c00826","article-title":"Nanoparticle-mediated simultaneous downregulation of placental Nrf2 and sFlt1 improves maternal and fetal outcomes in a preeclampsia mouse model","volume":"6","author":"Li","year":"2020","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.jconrel.2024.03.004_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.placenta.2017.07.360","article-title":"Modulating circulating sFlt1 in an animal model of preeclampsia using PAMAM nanoparticles for siRNA delivery","volume":"58","author":"Yu","year":"2017","journal-title":"Placenta"},{"key":"10.1016\/j.jconrel.2024.03.004_bb0210","doi-asserted-by":"crossref","first-page":"R81","DOI":"10.1530\/JOE-17-0185","article-title":"Treating the dysfunctional placenta","volume":"234","author":"Sibley","year":"2017","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.jconrel.2024.03.004_bb0215","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/HYPERTENSIONAHA.120.15146","article-title":"Prediction of preeclampsia-related adverse outcomes with the sFlt-1 (soluble fms-like tyrosine kinase 1)\/PlGF (placental growth factor)-ratio in the clinical routine a real-world study","volume":"77","author":"Droge","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.jconrel.2024.03.004_bb0220","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.placenta.2022.07.020","article-title":"Diagnostic capacity of sFlt-1\/PlGF ratio in fetal growth restriction: a systematic review and meta-analysis","volume":"127","author":"Chen","year":"2022","journal-title":"Placenta"},{"key":"10.1016\/j.jconrel.2024.03.004_bb0225","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.placenta.2011.08.008","article-title":"Nitric oxide generation affects pro-and anti-angiogenic growth factor expression in primary human trophoblast","volume":"32","author":"Groesch","year":"2011","journal-title":"Placenta"},{"key":"10.1016\/j.jconrel.2024.03.004_bb0230","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.4155\/tde-2017-0084","article-title":"Drug delivery during pregnancy: how can nanomedicine be used?","volume":"8","author":"Joshi","year":"2017","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2024.03.004_bb0235","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/AOG.0b013e3182a9ca67","article-title":"Exclusion of pregnant women from industry-sponsored clinical trials","volume":"122","author":"Shields","year":"2013","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jconrel.2024.03.004_bb0240","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jconrel.2020.10.049","article-title":"Macropinocytosis as a cell entry route for peptide-functionalized and bystander nanoparticles","volume":"329","author":"Li","year":"2021","journal-title":"J. Control. Release"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924001561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924001561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T21:35:21Z","timestamp":1738100121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924001561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":48,"alternative-id":["S0168365924001561"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.03.004","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Placenta-anchored tadalafil liposomes rescues intrauterine growth restriction through continuous placental blood perfusion improvement","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}